Login / Signup

Intestinal fatty acid binding protein is a disease biomarker in paediatric coeliac disease and Crohn's disease.

Michael LoganMary MacKinderClare Martha ClarkAikaterini KountouriMwansa JereUmer Zeeshan IjazRichard HansenParaic McGroganRichard Kay RussellKonstantinos Gerasimidis
Published in: BMC gastroenterology (2022)
Clinical Trials.gov, NCT02341248. Registered on 19/01/2015.
Keyphrases
  • clinical trial
  • binding protein
  • fatty acid
  • emergency department
  • intensive care unit
  • randomized controlled trial
  • open label
  • phase iii
  • double blind